Wang Qiaoli, Xu Guoqiang, Yan Ouying, Wang Shang, Wang Xin
Department of Radiation Oncology/Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Department of Oncology, Wenjiang District People's Hospital of Chengdu, Chengdu, People's Republic of China.
Therap Adv Gastroenterol. 2025 Jun 16;18:17562848251347347. doi: 10.1177/17562848251347347. eCollection 2025.
Although radiotherapy is the second most effective cancer treatment, radiation injuries limit its use. About 80% of abdominal-pelvic radiotherapy patients develop acute radiation enteritis, with 20% discontinuing radiotherapy. The lack of effective mitigation measures restricts its clinical application. Recent studies have proposed gut microbiota as a potential biomarker for radiation injuries. However, the interaction between gut microbiota and radiation injuries remains poorly understood. This review summarizes two forms of interaction between gut microbiota and radiation injuries based on the location of the radiation field. One type of interaction, referred to as "direct interaction," involves changes in the diversity and composition of gut microbiota, alterations in microbiota-derived metabolites, disruption of the intestinal barrier, activation of inflammatory responses within the intestine, and involvement of the host's immune system. The second form, called "indirect interaction," includes the influence of the gut microbiota on various body systems, such as gut microbiota-brain axis, gut microbiota-cardiopulmonary axis, and gut microbiota-oral axis. Additionally, we examine promising interventions aimed at reshaping the gut microbiota, including the use of probiotics, prebiotics, and fecal microbiota transplantation. The interaction between radiation injuries and gut microbiota is more complex than previously understood. Therefore, further clarification of the underlying mechanisms will facilitate the application of gut microbiota in preventing and alleviating radiation injuries.
尽管放射治疗是第二有效的癌症治疗方法,但辐射损伤限制了其应用。约80%的腹部盆腔放射治疗患者会发生急性放射性肠炎,其中20%的患者会中断放射治疗。缺乏有效的缓解措施限制了其临床应用。最近的研究提出肠道微生物群作为辐射损伤的潜在生物标志物。然而,肠道微生物群与辐射损伤之间的相互作用仍知之甚少。本综述基于辐射野的位置总结了肠道微生物群与辐射损伤之间的两种相互作用形式。一种相互作用类型称为“直接相互作用”,涉及肠道微生物群的多样性和组成变化、微生物衍生代谢物的改变、肠道屏障的破坏、肠道内炎症反应的激活以及宿主免疫系统的参与。第二种形式称为“间接相互作用”,包括肠道微生物群对各种身体系统的影响,如肠道微生物群-脑轴、肠道微生物群-心肺轴和肠道微生物群-口腔轴。此外,我们研究了旨在重塑肠道微生物群的有前景的干预措施,包括使用益生菌、益生元以及粪便微生物群移植。辐射损伤与肠道微生物群之间的相互作用比以前认为的更为复杂。因此,进一步阐明潜在机制将有助于肠道微生物群在预防和减轻辐射损伤中的应用。